A panel of experts has voted against a Duchenne muscular dystrophy drug from PTC Therapeutics (NASDAQ: PTCT). The vote is a critical blow to the company’s unusual attempt to force the review of a drug the FDA has rejected twice... Read more »
The venture rounds are over for Kyriba, a cloud-based provider of corporate treasury and financial management software that is based in New York and San Diego.
After raising $23 million in a Series D funding round last September, Kyriba says... Read more »
Tech giants are under a lot of pressure these days to make the world a better place—to ferret out Russian hackers trying to fix elections; to combat gender bias in hiring; to stamp out sexual harassment; and to lend their voices... Read more »
We are excited to announce the recipients of the first-ever Xconomy Awards.
The Bridge Project was hatched by MIT’s Koch Institute for Integrative Cancer Research in Cambridge and the Dana-Farber/Harvard Cancer Center in Boston to fund... Read more »
Another high-profile attempt to produce an Alzheimer’s treatment has failed.
An unusual biotech company called Axovant Sciences (NASDAQ: AXON) reported today that its drug intepirdine did not show a meaningful difference between the patients taking a combination of intepirdine and... Read more »
President Donald Trump, who has had a rocky relationship with tech companies during his short administration so far, announced an education initiative Monday that apparently met with their approval.
In a White House ceremony, Trump directed his education secretary to allocate... Read more »
[Updated 9/25/17, 1:55 p.m. Clarified 9/27/17, 10:01 a.m. See below.] Immigration policy has always been important to the tech industry, but this year is different. Under a steady barrage of nationalist, anti-immigrant policies promulgated by the Trump administration, the... Read more »
[Updated 9/25/17, 5:18 pm. See below.] Food delivery startups are catching on with more consumers, and that demand is whetting investor appetites.
The $400 million that grocery delivery startup Instacart raised in March marked the largest deal for a... Read more »
Pfizer is testing out a new biotech experiment this morning. It has taken four drug compounds gathering dust on its shelves, and funneled them into a new startup, SpringWorks Therapeutics, that will try to develop them for diseases that don’t fit... Read more »